179 related articles for article (PubMed ID: 2591447)
1. Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
Meier W; Eiermann W; Stieber P; Schneider A; Fateh-Moghadam A; Hepp H
Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1555-9. PubMed ID: 2591447
[TBL] [Abstract][Full Text] [Related]
2. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
[TBL] [Abstract][Full Text] [Related]
3. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
4. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
Geyer H; Schwörer D; Pfleiderer A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma antigen in cervical cancer.
Borras G; Molina R; Xercavins J; Ballesta A; Iglesias X
Eur J Gynaecol Oncol; 1992; 13(5):414-8. PubMed ID: 1486921
[TBL] [Abstract][Full Text] [Related]
6. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
de Bruijn HW; Duk JM; van der Zee AG; Pras E; Willemse PH; Boonstra H; Hollema H; Mourits MJ; de Vries EG; Aalders JG
Tumour Biol; 1998; 19(6):505-16. PubMed ID: 9817980
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancer.
Pectasides D; Economides N; Bourazanis J; Pozadzizou P; Gogou L; Koutsiouba P; Athanassiou A
Am J Clin Oncol; 1994 Aug; 17(4):307-12. PubMed ID: 8048392
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
Gocze PM; Vahrson HW; Freeman DA
Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
[TBL] [Abstract][Full Text] [Related]
13. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
Tabata T; Takeshima N; Tanaka N; Hirai Y; Hasumi K
Tumour Biol; 2000; 21(6):375-80. PubMed ID: 11006578
[TBL] [Abstract][Full Text] [Related]
15. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
Avall-Lundqvist EH; Sjövall K; Nilsson BR; Eneroth PH
Eur J Cancer; 1992; 28A(10):1695-702. PubMed ID: 1389488
[TBL] [Abstract][Full Text] [Related]
17. Cervical carcinoma: a comparison of four potential biochemical tumor markers.
Dodd JK; Henry RJ; Tyler JP; Houghton CR
Gynecol Oncol; 1989 Feb; 32(2):248-52. PubMed ID: 2910788
[TBL] [Abstract][Full Text] [Related]
18. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
Lehtovirta P; Viinikka L; Ylikorkala O
Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
[TBL] [Abstract][Full Text] [Related]
19. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma antigen for monitoring cervical cancer.
Schmidt-Rhode P; Schulz KD; Sturm G; Häfner H; Prinz H; Künzig HJ
Int J Biol Markers; 1988; 3(2):87-94. PubMed ID: 3243981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]